Home › Funds › TREMBLANT CAPITAL GROUP › INSM
TREMBLANT CAPITAL GROUP position in INSM
INSMED INC · Health Care
TREMBLANT CAPITAL GROUP reported holding 168,698 shares of INSM (INSMED INC) in its Q3 2026 13F filing — a position valued at US$19.3M, representing 0.59% of its reported portfolio and ranking #49 among its reported holdings. TREMBLANT CAPITAL GROUP has disclosed INSM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How TREMBLANT CAPITAL GROUP's INSM position evolved
TREMBLANT CAPITAL GROUP first disclosed a stake in INSM in Q4 2025 at 175,650 shares (US$30.6M). Across 4 filings, TREMBLANT CAPITAL GROUP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 168,698 shares valued at US$19.3M — a reduction of -1,972 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 175.65K | $30.57M | New |
| Q1 2026 | 173.64K | $28.39M | Reduce |
| Q2 2026 | 170.67K | $18.20M | Reduce |
| Q3 2026 | 168.70K | $19.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 42 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Orbis Allan Gray Ltd (US$768.6M), Darwin Global Management, Ltd. (US$673.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- BAKER BROS. ADVISORS LP 8.80M sh · $937.84M · Q2 2026
- Orbis Allan Gray Ltd 6.73M sh · $768.62M · Q3 2026
- Darwin Global Management, Ltd. 6.43M sh · $673.60M · Q2 2026
- Artisan Partners Limited Partnership 5.58M sh · $636.68M · Q3 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- RTW INVESTMENTS, LP 3.10M sh · $353.44M · Q3 2026
- Paradigm Biocapital Advisors LP 2.70M sh · $307.72M · Q3 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- MAVERICK CAPITAL LTD 2.15M sh · $229.31M · Q2 2026
- Polar Capital Holdings Plc 1.75M sh · $200.17M · Q3 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.55M sh · $177.20M · Q3 2026
- Deep Track Capital, LP 1.35M sh · $154.09M · Q3 2026
More on TREMBLANT CAPITAL GROUP
FAQ
How long has TREMBLANT CAPITAL GROUP held INSM?
TREMBLANT CAPITAL GROUP has disclosed INSM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is TREMBLANT CAPITAL GROUP's current position in INSM?
As of Q3 2026, TREMBLANT CAPITAL GROUP holds 168.70K shares of INSM (INSMED INC), valued at $19.26M, representing 0.59% of its reported portfolio and ranking #49.
Has TREMBLANT CAPITAL GROUP been buying or selling INSM?
In the latest 13F filing (Q3 2026), TREMBLANT CAPITAL GROUP reduced its position in INSM.
Which other funds hold INSM?
Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Orbis Allan Gray Ltd, Darwin Global Management, Ltd., among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.